Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice-Reference-Cited by-同舟云学术

Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice

Published:2013-06-12 Issue:10 Volume:133 Page:2473-2482
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tang Hexiao,Liao Yongde¹,Xu Liqiang,Zhang Chao,Liu Zhaoguo,Deng Yu¹,Jiang Zhixiao¹,Fu Shengling¹,Chen Zhenguang²,Zhou Sheng³

Affiliation:

1. Department of Thoracic Surgery; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan; Hubei Province; China

2. Department of Thoracic Surgery; The First Affiliated Hospital, Sun Yat-Sen University; Guangzhou; China

3. Department of Pathology; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan; Hubei Province; China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma;Niikawa;Clin Cancer Res,2008

3. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands;Hershberger;Cancer Res,2005

4. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma;Hammoud;Endocr Relat Cancer,2008

5. Estrogen promotes benzo[a]pyrene-induced lung carcinogenesis through oxidative stress damage and cytochrome c-mediated caspase-3 activation pathways in female mice;Chen;Cancer Lett,2011

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-based differences in the lung immune microenvironment are associated with an increased risk of lung cancer in women;The Journal of Thoracic and Cardiovascular Surgery;2024-07

2. High Dose of Estrogen Protects the Lungs from Ischemia–Reperfusion Injury by Downregulating the Angiotensin II Signaling Pathway;Inflammation;2024-02-22

3. METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis;Cell & Bioscience;2024-01-18

4. METTL3 Drives NSCLC Metastasis by Enhancing CYP19A1 Translation and Oestrogen Synthesis;2023-11-17

5. The impact of inflammation and acute phase activation in cancer cachexia;Frontiers in Immunology;2023-10-31